Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1960 1
1964 1
1965 3
1966 2
1967 1
1968 3
1969 2
1970 4
1971 1
1972 5
1973 3
1974 2
1975 4
1976 6
1977 1
1978 5
1979 1
1980 2
1981 1
1982 1
1983 6
1984 6
1985 3
1986 4
1987 5
1988 2
1989 2
1990 9
1991 3
1992 2
1993 1
1994 3
1995 1
1996 2
1997 1
1998 2
1999 5
2000 2
2001 1
2002 4
2003 4
2004 2
2005 5
2006 3
2007 3
2008 6
2009 5
2010 7
2011 5
2012 2
2013 2
2014 2
2015 6
2016 2
2017 8
2018 9
2019 15
2020 12
2021 21
2022 15
2023 13
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

253 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
André T, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, Smith D, Garcia-Carbonero R, Benavides M, Gibbs P, de la Fouchardiere C, Rivera F, Elez E, Bendell J, Le DT, Yoshino T, Van Cutsem E, Yang P, Farooqui MZH, Marinello P, Diaz LA Jr; KEYNOTE-177 Investigators. André T, et al. Among authors: jensen lh. N Engl J Med. 2020 Dec 3;383(23):2207-2218. doi: 10.1056/NEJMoa2017699. N Engl J Med. 2020. PMID: 33264544 Free article. Clinical Trial.
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study.
Diaz LA Jr, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, Smith D, Garcia-Carbonero R, Benavides M, Gibbs P, de la Fourchardiere C, Rivera F, Elez E, Le DT, Yoshino T, Zhong WY, Fogelman D, Marinello P, Andre T; KEYNOTE-177 Investigators. Diaz LA Jr, et al. Among authors: jensen lh. Lancet Oncol. 2022 May;23(5):659-670. doi: 10.1016/S1470-2045(22)00197-8. Epub 2022 Apr 12. Lancet Oncol. 2022. PMID: 35427471 Free PMC article. Clinical Trial.
Patients with cancer and pre-existing severe mental disorder.
Fløe LE, Vendelsøe ANH, Jensen LH, Stie M, Hjorth P, Søndergaard J, Mygind A, Videbech P, Eriksen JG, Bentson TM, Bruun JM, Johnsen SP, Neergaard MA. Fløe LE, et al. Among authors: jensen lh. Ugeskr Laeger. 2024 Aug 19;186(34):V09230604. doi: 10.61409/V09230604. Ugeskr Laeger. 2024. PMID: 39234885 Free article. Review. Danish.
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T, Amonkar M, Norquist JM, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt CJA, Smith D, Garcia-Carbonero R, Sevilla I, De La Fouchardiere C, Rivera F, Elez E, Diaz LA Jr, Yoshino T, Van Cutsem E, Yang P, Farooqui M, Le DT. Andre T, et al. Among authors: jensen lh. Lancet Oncol. 2021 May;22(5):665-677. doi: 10.1016/S1470-2045(21)00064-4. Epub 2021 Apr 1. Lancet Oncol. 2021. PMID: 33812497 Clinical Trial.
International Validation of the Immunoscore Biopsy in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy.
El Sissy C, Kirilovsky A, Lagorce Pagès C, Marliot F, Custers PA, Dizdarevic E, Sroussi M, Castillo-Martin M, Haicheur N, Dermani M, Loche N, Buttard B, Musina AM, Anitei MG, van den Berg JG, Broeks A, Iseas S, Coraglio M, Loria FS, Romero A, Laurent-Puig P, de Reyniès A, Fernandez LM, Karoui M, Tougeron D, Vaccaro CA, Santino JP, Poulsen LØ, Lindebjerg J, O'Connor JM, Scripcariu V, Dimofte MG, Gérard JP, Chalabi M, Figueiredo N, Perez RO, Habr-Gama A, Galon J, Hansen TF, Jensen LH, Beets G, Zeitoun G, Pagès F. El Sissy C, et al. Among authors: jensen lh. J Clin Oncol. 2024 Jan 1;42(1):70-80. doi: 10.1200/JCO.23.00586. Epub 2023 Oct 3. J Clin Oncol. 2024. PMID: 37788410 Free PMC article.
Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer.
Yoshino T, Andre T, Kim TW, Yong WP, Shiu KK, Jensen BV, Jensen LH, Punt CJA, Smith D, Garcia-Carbonero R, Alcaide-Garcia J, Gibbs P, de la Fouchardiere C, Rivera F, Elez E, Le DT, Adachi N, Fogelman D, Marinello P, Diaz LA Jr. Yoshino T, et al. Among authors: jensen lh. Cancer Sci. 2023 Mar;114(3):1026-1036. doi: 10.1111/cas.15650. Epub 2022 Dec 12. Cancer Sci. 2023. PMID: 36369901 Free PMC article. Clinical Trial.
Treosulfan in platinum-resistant ovarian cancer.
Olesen KD, Larsen ATR, Jensen LH, Steffensen KD, Søndergaard SR. Olesen KD, et al. Among authors: jensen lh. Int J Gynecol Cancer. 2021 Jul;31(7):1045-1051. doi: 10.1136/ijgc-2021-002395. Epub 2021 May 18. Int J Gynecol Cancer. 2021. PMID: 34006568
Systematic review of the prevalence of onychomycosis in children.
Vestergaard-Jensen S, Mansouri A, Jensen LH, Jemec GBE, Saunte DML. Vestergaard-Jensen S, et al. Among authors: jensen lh. Pediatr Dermatol. 2022 Nov;39(6):855-865. doi: 10.1111/pde.15100. Epub 2022 Sep 21. Pediatr Dermatol. 2022. PMID: 36130720 Free PMC article. Review.
253 results